3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Sleep Initiation and Maintenance Disorders
28
Neoplasms
20
Breast Neoplasms
18
Depression
10
Anxiety Disorders
9
Prostatic Neoplasms
6
Lung Neoplasms
5
Fatigue
5
Motor Activity
4
Weight Loss
3
Melanoma
3
Chronic Pain
3
Uterine Cervical Neoplasms
2
Smoking Cessation
2
Sleep Wake Disorders
2
Pain
2
Overweight
2
Obesity
2
Nervous System Diseases
2
Multiple Myeloma
2
Lymphoma
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Carcinoma, Non-Small-Cell Lung
2
Weight Gain
1
Uterine Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Stress, Psychological
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Counseling
4
Psychiatric Rehabilitation
3
methyl 3-mercaptopropionimidate
1
Vitamin E
1
Vitamin D
1
Sildenafil Citrate
1
Sexual Health
1
Sex Education
1
Robotics
1
Restraint, Physical
1
Radiotherapy
1
Radiosurgery
1
Mindfulness-Based Stress Reduction
1
Menogaril
1
Laparoscopy
1
Hormonal Contraception
1
Family Characteristics
1
Exercise
1
Diet Therapy
1
Cognitive Behavioral Therapy
1
Coconut Oil
1
Arginine
1
ArginMax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Sexual Dysfunction, Physiological
×
Cognitive Behavioral Therapy
×
Clear all
NCT03365518
2021-04-27
INTROSPPECT
University of British Columbia
Phase NA
Completed
100 enrolled